Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bernd Antkowiak & Gerhard Rammes. (2019) GABA(A) receptor-targeted drug development -New perspectives in perioperative
anesthesia. Expert Opinion on Drug Discovery 14:7, pages 683-699.
Read now
Read now
Articles from other publishers (25)
Yusufu Mahemuti, Kaheerman Kadeer, Riqing Su, Abudureheman Abula, Yirizhati Aili, Aierpati Maimaiti, Subinuer Abulaiti, Maimaitiyasheng Maimaitituerxun, Tong Miao, Shihao Jiang, Aximujiang Axier, Maimaitili Aisha, Yongxin Wang & Xiaojiang Cheng. (2023) TSPO exacerbates acute cerebral ischemia/reperfusion injury by inducing autophagy dysfunction. Experimental Neurology, pages 114542.
Crossref
Crossref
O. A. Deeva, M. A. Yarkova, G. V. Mokrov, T. A. Gudasheva & S. B. Seredenin. (2022) Dipeptide Ligands of TSPO. Pharmaceutical Chemistry Journal 56:9, pages 1169-1178.
Crossref
Crossref
Rochelle M. Hines, Elaine A. Aquino, Matthew I. Khumnark, Maria P. Dávila & Dustin J. Hines. (2022) Comparative Assessment of TSPO Modulators on Electroencephalogram Activity and Exploratory Behavior. Frontiers in Pharmacology 13.
Crossref
Crossref
Ido Ben-Shalom, Arnon Karni & Hadar Kolb. (2021) The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis. International Journal of Molecular Sciences 23:1, pages 474.
Crossref
Crossref
L. Zainullina, M. Sadowsky, G. Mokrov, S. Kotelnikova, Y. Vakhitova, T. Gudasheva & S. Seredenin. (2021) P.0864 Novel pyrrolo[1,2-a]pyrazines TSPO ligands ameliorate SH-SY5Y cells survival upon lipopolysaccharide-induced cell damage. European Neuropsychopharmacology 53, pages S631-S632.
Crossref
Crossref
Livia J. De Picker & Benno C. M. Haarman. (2021) Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker. European Journal of Nuclear Medicine and Molecular Imaging 49:1, pages 164-173.
Crossref
Crossref
D. V. Maltsev, A. A. Spasov, M. V. Miroshnikov & M. O. Skripka. (2021) Current Approaches to the Search of Anxiolytic Drugs. Russian Journal of Bioorganic Chemistry 47:3, pages 622-652.
Crossref
Crossref
Dario Fiorenza, Emanuele Nicolai, Carlo Cavaliere, Ferdinando Fiorino, Giovanna Esposito & Marco Salvatore. (2021) Fully Automated Synthesis of Novel TSPO PET Imaging Ligand [18F]Fluoroethyltemazepam. Molecules 26:8, pages 2372.
Crossref
Crossref
Renee Sokias, Eryn L. Werry, Hei Wun Alison Cheng, James H. Lloyd, Greta Sohler, Jonathan J. Danon, Andrew P. Montgomery, Jonathan J. Du, Quanqing Gao, David E. Hibbs, Lars M. Ittner, Tristan A. Reekie & Michael Kassiou. (2020) Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism. European Journal of Medicinal Chemistry 207, pages 112725.
Crossref
Crossref
Tatiana A. Gudasheva, Olga A. Deeva, Andrey S. Pantileev, Grigory V. Mokrov, Inna V. Rybina, Milada A. Yarkova & Sergei B. Seredenin. (2020) The New Dipeptide TSPO Ligands: Design, Synthesis and Structure–Anxiolytic Activity Relationship. Molecules 25:21, pages 5132.
Crossref
Crossref
Jasmina Dimitrova-Shumkovska, Ljupcho Krstanoski & Leo Veenman. (2020) Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update. Cells 9:4, pages 870.
Crossref
Crossref
Younghwan Lee, Youngjin Park, Hyeri Nam, Ji-Won Lee & Seong-Woon Yu. (2020) Translocator protein (TSPO): the new story of the old protein in neuroinflammation. BMB Reports 53:1, pages 20-27.
Crossref
Crossref
Agostino Bruno, Elisabetta Barresi, Nicola Simola, Eleonora Da Pozzo, Barbara Costa, Ettore Novellino, Federico Da Settimo, Claudia Martini, Sabrina Taliani & Sandro Cosconati. (2019) Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations. ACS Chemical Neuroscience 10:8, pages 3805-3814.
Crossref
Crossref
Stefanie Bader, Luisa Wolf, Vladimir M. Milenkovic, Michael Gruber, Caroline Nothdurfter, Rainer Rupprecht & Christian H. Wetzel. (2019) Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells. Psychoneuroendocrinology 106, pages 65-76.
Crossref
Crossref
Neydher Berroterán-Infante, Monika Tadić, Marcus Hacker, Wolfgang Wadsak & Markus Mitterhauser. (2019) Binding Affinity of Some Endogenous and Synthetic TSPO Ligands Regarding the rs6971 Polymorphism. International Journal of Molecular Sciences 20:3, pages 563.
Crossref
Crossref
Katsushi Kumata, Yiding Zhang, Masayuki Fujinaga, Takayuki Ohkubo, Wakana Mori, Tomoteru Yamasaki, Masayuki Hanyu, Lin Xie, Akiko Hatori & Ming-Rong Zhang. (2018) [18F]DAA1106: Automated radiosynthesis using spirocyclic iodonium ylide and preclinical evaluation for positron emission tomography imaging of translocator protein (18 kDa). Bioorganic & Medicinal Chemistry 26:17, pages 4817-4822.
Crossref
Crossref
Juan Zeng, Riccardo Guareschi, Mangesh Damre, Ruyin Cao, Achim Kless, Bernd Neumaier, Andreas Bauer, Alejandro Giorgetti, Paolo Carloni & Giulia Rossetti. (2018) Structural Prediction of the Dimeric Form of the Mammalian Translocator Membrane Protein TSPO: A Key Target for Brain Diagnostics. International Journal of Molecular Sciences 19:9, pages 2588.
Crossref
Crossref
Neydher Berroterán-Infante, Theresa Balber, Petra Fürlinger, Michael Bergmann, Rupert Lanzenberger, Marcus Hacker, Markus Mitterhauser & Wolfgang Wadsak. (2018)
[
18
F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer
. ACS Medicinal Chemistry Letters 9:3, pages 177-181.
Crossref
Crossref
V. Papadopoulos, J. Fan & B. Zirkin. (2018) Translocator protein (18 kDa): an update on its function in steroidogenesis. Journal of Neuroendocrinology 30:2, pages e12500.
Crossref
Crossref
Ga Kim, Jin Paeng, Jae Jung, Byung Moon, Antonio Lopalco, Nunzio Denora, Byung Lee & Sang Kim. (2018) Assessment of TSPO in a Rat Experimental Autoimmune Myocarditis Model: A Comparison Study between [18F]Fluoromethyl-PBR28 and [18F]CB251. International Journal of Molecular Sciences 19:1, pages 276.
Crossref
Crossref
S. Giatti, R. Mastrangelo, M. D'Antonio, M. Pesaresi, S. Romano, S. Diviccaro, D. Caruso, N. Mitro & R.C. Melcangi. (2018) Neuroactive steroids and diabetic complications in the nervous system. Frontiers in Neuroendocrinology 48, pages 58-69.
Crossref
Crossref
Moshe Gavish & Leo Veenman. 2018. Apprentices to Genius: A tribute to Solomon H. Snyder. Apprentices to Genius: A tribute to Solomon H. Snyder
103
136
.
Barbara Costa, Sabrina Taliani, Eleonora Da Pozzo, Elisabetta Barresi, Marco Robello, Chiara Cavallini, Sandro Cosconati, Federico Da Settimo, Ettore Novellino & Claudia Martini. (2017)
Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of
N
,
N
-Dialkyl-2-arylindol-3-ylglyoxylamides
. ChemMedChem 12:16, pages 1275-1278.
Crossref
Crossref
Ahmed Elkamhawy, Jung-eun Park, Ahmed H.E. Hassan, Ae Nim Pae, Jiyoun Lee, Beoung-Geon Park, Sora Paik, Jimin Do, Jong-Hyun Park, Ki Duk Park, Bongjin Moon, Woo Kyu Park, Heeyeong Cho, Dae Young Jeong & Eun Joo Roh. (2017) Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2 H )-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP opening. European Journal of Pharmaceutical Sciences 104, pages 366-381.
Crossref
Crossref
Nasra Yasin, Leo Veenman, Sukhdev Singh, Maya Azrad, Julia Bode, Alex Vainshtein, Beatriz Caballero, Ilan Marek & Moshe Gavish. (2017) Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling. International Journal of Molecular Sciences 18:4, pages 786.
Crossref
Crossref